Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Michele Malagola, Nicola Polverelli, Massimo Martino, Vicky Rubini, Maria Teresa Lupo Stanghellini, Francesca Patriarca, Renato Fanin, Benedetto Bruno, Luisa Giaccone, Danilo Giuseppe Faraci, Giovanni Grillo, Stefania Bramanti, Luca Castagna, Paolo Bernasconi, Anna Amelia Colombo, Marco De Gobbi, Paolo Nicoli, Annalisa Natale, Stella Santarone, Elisabetta Terruzzi, Attilio Olivieri, Ilaria Scortechini, Patrizia Chiusolo, Elisabetta Metafuni, Angelo Michele Carella, Emanuela Merla, Marco Casini, Irene M Cavattoni, Mario Arpinati, Chiara Nozzoli, Ilaria Cutini, Patrizio Mazza, Annamaria Mazzone, Simona Bassi, Francesco Onida, Giorgia Saporiti, Filippo Antonio Canale, Adriana Vacca, Eugenia Piras, Piero Galieni, Sadia Falcioni, Mario Luppi, Giulia Debbia, Anna Paola Iori, Ursula La Rocca, Vincenzo Pavone, Anna Mele, Cristina Skert, Francesca Carobolante, Paola Carluccio, Carlo Borghero, Francesca Elice, Anna Proia, Fulvia Fanelli, Carmine Selleri, Nicoletta Sacchi, Sonia Mammoliti, Elena Oldani, Fabio Ciceri, Francesca Bonifazi, Domenico Russo

Blood (2021) 138 (Supplement 1): 1786.

https://doi.org/10.1182/blood-2021-145970

Published: 2021

Journal Articles

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry

Blood (2011) 118 (21): 2009.

https://doi.org/10.1182/blood.V118.21.2009.2009

Published: 2011

Journal Articles

Role of Histopathology in Management of Graft Versus Host Disease (GVHD). A Single Centre Experience.

Irene Maria Cavattoni, MD, Enrico Morello, MD, Norbert Pescosta, MD, Marco Casini, MD, Giovanni Negri, Vito Colombetti, Sergio Cortelazzo, MD

Blood (2009) 114 (22): 4647.

https://doi.org/10.1182/blood.V114.22.4647.4647

Published: 2009

Journal Articles

Induction with New Drugs and Planned Autologous Followed by Non-Myeloablative Allogeneic Transplantation in Newly Diagnosed Myeloma.

Luisa Giaccone, Moreno Festuccia, Roberto Sorasio, Nicola Mordini, Fabrizio Carnevale Schianca, Francesca Patriarca, Marco Casini, Anna Paola Iori, Robin Foà, Mario Boccadoro, Benedetto Bruno

Blood (2009) 114 (22): 4330.

https://doi.org/10.1182/blood.V114.22.4330.4330

Published: 2009

Journal Articles

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Blood (2009) 113 (14): 3375–3382.

https://doi.org/10.1182/blood-2008-07-167379

Published: 2009

Journal Articles

Reduced Intensity Conditioning with Thiotepa and Fludarabine for Allogeneic Transplantation: Evidence for Low Toxicity and Long-Lasting Disease Control in MDS with Low/Intermediate-1 IPSS Score and in AML from MDS in Complete Remission.

Emilio Paolo Alessandrino, Luca Malcovati, Giorgio La Nasa, Paolo de Fabritiis, Massimo Bernardi, Paolo Di Bartolomeo, Paolo Bernasconi, Anna A Colombo, Daniela Caldera, Cristiana Pascutto, Patrizio Mazza, Franco Narni, Rosanna Scime’, Attilio Olivieri, Marco Casini, Andrea Bacigalupo for GITMO

Blood (2008) 112 (11): 3285.

https://doi.org/10.1182/blood.V112.11.3285.3285

Published: 2008

Journal Articles

Herpes Simplex Virus Encephalitis (HSE) after Allogeneic Hematopoietic Stem Cell Transplatation (alloHSCT): Impact of Early Diagnosis and Treatment on Outcome.

Irene M. Cavattoni, MD, Enrico Morello, M.D., Marco Casini, M.D., Norma Decaminada, M.D., Leonardo Pagani, M.D., Pietro Fabris, M.D., Sergio Cortelazzo, M.D.

Blood (2007) 110 (11): 5002.

https://doi.org/10.1182/blood.V110.11.5002.5002

Published: 2007

Journal Articles

Impact of Prophylaxis with Aerosolized Amphotericin-B Deoxycholate (d-AmB) on Respiratory Tract Invasive Fungal Infections (IFIs) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Enrico Morello, MD, Irene M. Cavattoni, M.D., Pietro Fabris, M.D., Silvia Coin, B.S.C., Barbara Amato, M.D., Vincenzo Cassibba, M.D., Marco Casini, M.D., Leonardo Pagani, M.D., Sergio Cortelazzo, M.D.

Blood (2007) 110 (11): 4986.

https://doi.org/10.1182/blood.V110.11.4986.4986

Published: 2007

Journal Articles

A Randomized Trial of Bone Marrow (BM) Versus Peripheral Blood (PB) Allogeneic Hemopoietic Stem Cell Transplants (HSCT) in Patients with Myeloproliferative Disorders.

Andrea Bacigalupo, Maria Teresa van Lint, Attilio Olivieri, Marco Casini, Emanuele Angelucci, Franco Narni, Carmine Selleri, Paolo Di Bartolomeo, Fabio Ciceri, Renato Fanin

Blood (2006) 108 (11): 2998.

https://doi.org/10.1182/blood.V108.11.2998.2998

Published: 2006

Journal Articles

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

Blood (2005) 106 (1): 27–34.

https://doi.org/10.1182/blood-2004-09-3728

Published: 2005

Journal Articles

Low Dose TBI Based Nonmyeloablative Conditionings for Allografting in Multiple Myeloma: Impact of Disease Status at Transplant.

Luisa Giaccone, MD, Marcello Rotta, MD, Bernardino Allione, MD, Fabrizio Carnevale-Schianca, MD, Carlo Rosanelli, MD, Giovannino Ciccone, MD, Marco Casini, MD, Antonio Capaldi, MD, Gabriele Aitoro, MD, Paola Omedè, PhD, Silvano Battaglio, PhD, Massimo Massaia, MD, Paolo Coser, MD, Massimo Aglietta, MD, Alessandro Levis, MD, Rainer Storb, MD, Benedetto Bruno, MD, PhD, Mario Boccadoro, MD

Blood (2004) 104 (11): 2310.

https://doi.org/10.1182/blood.V104.11.2310.2310

Published: 2004

NARROW

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry

Role of Histopathology in Management of Graft Versus Host Disease (GVHD). A Single Centre Experience.

Induction with New Drugs and Planned Autologous Followed by Non-Myeloablative Allogeneic Transplantation in Newly Diagnosed Myeloma.

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Reduced Intensity Conditioning with Thiotepa and Fludarabine for Allogeneic Transplantation: Evidence for Low Toxicity and Long-Lasting Disease Control in MDS with Low/Intermediate-1 IPSS Score and in AML from MDS in Complete Remission.

Herpes Simplex Virus Encephalitis (HSE) after Allogeneic Hematopoietic Stem Cell Transplatation (alloHSCT): Impact of Early Diagnosis and Treatment on Outcome.

Impact of Prophylaxis with Aerosolized Amphotericin-B Deoxycholate (d-AmB) on Respiratory Tract Invasive Fungal Infections (IFIs) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

A Randomized Trial of Bone Marrow (BM) Versus Peripheral Blood (PB) Allogeneic Hemopoietic Stem Cell Transplants (HSCT) in Patients with Myeloproliferative Disorders.

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

Low Dose TBI Based Nonmyeloablative Conditionings for Allografting in Multiple Myeloma: Impact of Disease Status at Transplant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only